Icahn Alum Alex Denner Thrives on Popping Drug Stocks

November 10, 2017   Stephen Taub

Sarissa Capital Management is one of the top performing activists so far this year.

Sarissa Capital Management’s chief investment officer Alexander Denner knows very well that specializing in drug, biotech and other health care stocks can be volatile. This year is a prime example. The Icahn Capital alum and Tiger grandcub runs one of …

Subscribe

Subscribers have unlimited access to all online content inc rankings. Start your subscription today - click on the button below.

Subscribe now

Free trial

Taking a free trial will give you access to online content one week (excludes research & rankings). Start your trial today.

Free Trial




Latest Poll

How will hedge funds finish 2017?

 - 73%
 - 11%
 - 15%

View previous results